At this point, the medical use of cannabis is legal in 37 states and the District of Columbia (D.C.). The recreational use of cannabis has been legalized in 21 states and D.C. The downstream effect [...]
I am taking care of a patient with a history of severe recurrent depression. Although she did relatively well during pregnancy on duloxetine 120 mg, she experienced recurrent, severe depressive symptoms after giving birth. [...]
While data are limited regarding AEDs and breastfeeding, it appears that none of the AEDs are excreted at high levels into the breast milk, nor have they been associated with high rates of adverse events in the nursing infant.
The PLLR helps to put the potential effects of the drug into perspective with the goal of providing a more individualized risk-benefit analysis.
Essential Reads – Psychotropic Treatment During Pregnancy: Research Synthesis and Clinical Care Principles
This review article provides clinically relevant data but also helps the reader navigate some of the more controversial issues in the field.
Lamotrigine is detected in the breast milk and in the serum of the nursing infant; however, the risk of adverse events is very low.
Because women with bipolar disorder are at high risk for relapse during the postpartum period, we typically recommend that women continue treatment with lithium throughout the postpartum period. While this intervention clearly decreases risk for postpartum psychiatric illness, the use of lithium while breastfeeding presents certain challenges.
Many women taking stimulants question whether it is safe to take these medications while breastfeeding.
A significant number of women consume cannabis while breastfeeding. What do we know about the effects of cannabis on the nursing infant?
Despite the increasing use of the newer “atypical” or second-generation antipsychotic agents to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and other anxiety disorders, we have relatively little data [...]